Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Group",
"id" : "170441",
"meta" : {
"versionId" : "7",
"lastUpdated" : "2024-11-16T19:29:13.976Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-cohort-definition"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Group 170441</b></p><a name=\"170441\"> </a><a name=\"hc170441\"> </a><a name=\"170441-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 7; Last updated: 2024-11-16 19:29:13+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-conceptual-cohort-definition.html\">ConceptualCohortDefinition</a></p></div><p><b>Artifact related artifact</b>: No display for RelatedArtifact (type: cite-as; citation: CohortDefinition: Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 170441. Revised 2022-09-09. Available at: https://fevir.net/resources/Group/170441. Computable resource at: https://fevir.net/resources/Group/170441.)</p><p><b>Artifact Author</b>: Brian S. Alper: </p><p><b>url</b>: <a href=\"https://fevir.net/resources/Group/170441\">https://fevir.net/resources/Group/170441</a></p><p><b>identifier</b>: FEvIR Object Identifier/https://fevir.net/FOI/170441</p><p><b>name</b>: ConceptualCohortDefinition_Cancer_of_any_kind_except_basal_cell_skin_cancer_or_cancer_in_situ_unless_documented_to_be_disease_free_for_five_years</p><p><b>status</b>: Active</p><p><b>date</b>: 2022-09-09 10:30:50+0000</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years</p>\n</div><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication</a>: Evidence Communication</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 CohortDefinition}\">CohortDefinition</span></td></tr></table><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>membership</b>: Conceptual</p><p><b>combinationMethod</b>: Except subset</p><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 64572001}, {http://hl7.org/fhir/fhir-types Condition}\">Disease (disorder)</span></p><p><b>value</b>: <span title=\"Codes:{http://snomed.info/sct 363346000}\">Malignant neoplastic disease (disorder)</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>Cancer of any kind</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 64572001}, {http://hl7.org/fhir/fhir-types Condition}\">Disease (disorder)</span></p><p><b>value</b>: <span title=\"Codes:{http://snomed.info/sct 254701007}\">Basal cell carcinoma of skin (disorder)</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>(except basal cell skin cancer)</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 64572001}, {http://hl7.org/fhir/fhir-types Condition}\">Disease (disorder)</span></p><p><b>value</b>: <span title=\"Codes:{http://snomed.info/sct 109355002}\">Carcinoma in situ (disorder)</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>(except cancer in situ)</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:{http://snomed.info/sct 395100000}\">No evidence of cancer found (situation)</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>unless documented to be disease-free for five years</p>\n</div><h3>Timings</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>ContextCode</b></td><td><b>Offset[x]</b></td><td><b>Text</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 450332002}\">Assessment of eligibility for clinical trial (procedure)</span></td><td>-5-0</td><td>for five years</td></tr></table></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
"valueRelatedArtifact" : {
"type" : "cite-as",
"citation" : "CohortDefinition: Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 170441. Revised 2022-09-09. Available at: https://fevir.net/resources/Group/170441. Computable resource at: https://fevir.net/resources/Group/170441."
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail" : {
"name" : "Brian S. Alper"
}
}
],
"url" : "https://fevir.net/resources/Group/170441",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "urn:ietf:rfc:3986",
"value" : "https://fevir.net/FOI/170441",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"name" : "ConceptualCohortDefinition_Cancer_of_any_kind_except_basal_cell_skin_cancer_or_cancer_in_situ_unless_documented_to_be_disease_free_for_five_years",
"status" : "active",
"date" : "2022-09-09T10:30:50.570Z",
"publisher" : "Computable Publishing LLC",
"contact" : [
{
"telecom" : [
{
"system" : "email",
"value" : "support@computablepublishing.com"
}
]
}
],
"description" : "Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years",
"useContext" : [
{
"code" : {
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "evidence-communication",
"display" : "Evidence Communication"
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "CohortDefinition",
"display" : "CohortDefinition"
}
]
}
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"membership" : "conceptual",
"combinationMethod" : "except-subset",
"characteristic" : [
{
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "64572001",
"display" : "Disease (disorder)"
},
{
"system" : "http://hl7.org/fhir/fhir-types",
"code" : "Condition",
"display" : "Condition"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "363346000",
"display" : "Malignant neoplastic disease (disorder)"
}
]
},
"exclude" : false,
"description" : "Cancer of any kind"
},
{
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "64572001",
"display" : "Disease (disorder)"
},
{
"system" : "http://hl7.org/fhir/fhir-types",
"code" : "Condition",
"display" : "Condition"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "254701007",
"display" : "Basal cell carcinoma of skin (disorder)"
}
]
},
"exclude" : true,
"description" : "(except basal cell skin cancer)"
},
{
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "64572001",
"display" : "Disease (disorder)"
},
{
"system" : "http://hl7.org/fhir/fhir-types",
"code" : "Condition",
"display" : "Condition"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "109355002",
"display" : "Carcinoma in situ (disorder)"
}
]
},
"exclude" : true,
"description" : "(except cancer in situ)"
},
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "395100000",
"display" : "No evidence of cancer found (situation)"
}
]
},
"exclude" : true,
"description" : "unless documented to be disease-free for five years",
"timing" : [
{
"contextCode" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "450332002",
"display" : "Assessment of eligibility for clinical trial (procedure)"
}
]
},
"offsetRange" : {
"low" : {
"value" : -5,
"system" : "http://unitsofmeasure.org"
},
"high" : {
"value" : 0,
"unit" : "years",
"system" : "http://unitsofmeasure.org",
"code" : "a"
}
},
"text" : "for five years"
}
]
}
]
}